AHA GUIDELINES Bundle (free trial)

Diagnosis and Management of Aortic Disease

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1483260

Contents of this Issue

Navigation

Page 84 of 97

85 Consider use of intravenous methylprednisolone 0.25–1 g/d for 3 d Target achieved? Start GC 40–60 mg/d Taper GCs to 15–20 mg/d within 2–3 mo and then to ≤5 mg/d after 1 y Minor relapse Increase GC to last effective dose Major relapse Diagnosis of Active Giant Cell Arteritis Increase GC to 40–60 mg/d GCA-related visual symptoms NO Modified from Hellmich, et al. Ann Rheum Dis. 2020;79:19-30. Copyright 2020, with permission from BMJ Publishing Group Limited.

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Diagnosis and Management of Aortic Disease